Recent & Archived News
November 26, 2018
FDA Approves Vitrakvi® (larotrectinib), the First Ever TRK Inhibitor, for Patients with Advanced Solid Tumors Harboring an NTRK Gene Fusion(1,2)
The U.S. Food and Drug Administration (FDA) today approved Vitrakvi® (larotrectinib), the first ever oral TRK inhibitor, for the treatment of adult and pediatric patients with solid tumors that...
November 19, 2018
The Climate Corporation Partners with Farmers Mutual Hail, Simplifies Crop Insurance Reporting for U.S. Farmers
The Climate Corporation, a subsidiary of Bayer, today announced a platform agreement with Farmers Mutual Hail Insurance Company of Iowa (FMH), enabling farmers to connect their field data to FMH...
November 14, 2018
Increased Consumer Risks from Purchasing Erectile Dysfunction Medicine on the Gray Market Exposed in New Research
Bayer and the National Consumers League (NCL) today released a white paper, Increased Consumer Risk from Erectile Dysfunction Medication Advertised and Sold on the Gray Market, which exposes the...
November 09, 2018
Bayer Names Finalists in Second Annual Alka-Rocket Challenge
Universities across the United States have spent months designing and constructing their Alka-Rocket in hopes of becoming a finalist in the Bayer Alka-Rocket challenge. For five university teams...
November 08, 2018
Pivot Bio, Bayer Announce Research Collaboration To Enhance Soybean Inoculant
Pivot Bio and Monsanto Company, a member of the Bayer Group, announced today a collaboration entered into earlier this year to develop Bradyrhizobium strains with enhanced nitrogen production for...
November 08, 2018
New survey finds about half of U.S. patients may have 'scanxiety' about diagnostic imaging procedures
In honor of today's International Day of Radiology, Bayer announced results from a global survey involving over 1,000 patients across seven countries to assess the patient experience with magnetic...
October 31, 2018
EPA Issues Continued Registration for XtendiMax® Herbicide with VaporGrip® Technology
Today, the Environmental Protection Agency (EPA) announced a continued registration, including label changes, for XtendiMax® Herbicide with VaporGrip® Technology, following an extensive review....
October 24, 2018
Phase III Trial of Darolutamide in Patients with Non-metastatic Castration-resistant Prostate Cancer Meets Primary Endpoint
The Phase III ARAMIS (Androgen Receptor inhibiting Agent for MetastatIc-free Survival) trial that investigated darolutamide in men with non-metastatic castration-resistant prostate cancer...
October 21, 2018
Larotrectinib Delivers 81% Overall Response Rate in an Expanded Dataset of 109 TRK Fusion Cancer Patients Across Ages and Tumor Types
Bayer and Loxo Oncology, Inc. (Nasdaq: LOXO), today announced updated clinical data for larotrectinib in adult and pediatric patients with TRK fusion cancer across 24 unique tumor types. The...
October 16, 2018
Bayer U.S. Appoints Scott Partridge General Counsel
Scott Partridge, former vice president of global strategy for Monsanto, now part of Bayer, has been named the company's U.S. General Counsel. Partridge, who succeeds former General Counsel Jan...
Want even more Bayer news?
Last Updated: September 24, 2018